Skip to main content

Table 3 Correlation between NT-proBNP Levels and Echocardiographic Parameters

From: Diagnostic accuracy of plasma NT-proBNP levels for excluding cardiac abnormalities in the very elderly

 

Tertiles of NT-proBNP*

 

Adjusted B (95% CI)

 
 

1 (n= 26)

2 (n= 27)

3 (n= 27)

Pfor trend

Model 1**, adjusted R2= 0.19

Model 2£, adjusted R2= 0.35

P

LV dimensions and systolic function

LV EDD (mm)

42 (39 - 51)

47 (43 - 54)

51 (45 - 56)

0.003

-0.042 (-0.088 - 0.005)

0.081

LV ESD (mm)

27 (22 - 31)

28 (27 - 33)

32 (29 - 37)

0.002

0.034 (-0.030 - 0.099)

0.29

LV Ejection fraction (%)

69 (60 - 79)

67 (61 - 72)

67 (53 - 74)

0.24

0.006 (-0.017 - 0.030)

0.59

LV Mass index (g/m2)

      

   Men

213 (182 - 287)

236 (177 - 260)

268 (209 - 372)

0.068

0.003 (0.000 - 0.005)

0.045

   Women

160 (142 - 190)

212 (169 - 242)

213 (160 - 260)

0.008

  

Left ventricular diastolic function

   E/A

0.61 (0.51 - 0.70)

0.72 (0.61 - 0.78)

0.70 (0.56 - 1.1)

0.016

0.45 (0.026 - 0.87)

0.038

   Left atrial volume (ml)

30.1 (22.1 - 40.0)

43.6 (25.6 - 55.3)

50.3 (33.8 - 73.6)

0.002

0.001 (-0.003 - 0.004)

0.67

Significant heart valvular disease

   Mitral regurgitation ≥ moderate

4 (11%)

18 (47%)

16 (42%)

0.003

-0.046 (-0.14 - 0.045)$

0.32

   Aortic regurgitation ≥ moderate

3 (13%)

8 (35%)

12 (52%)

0.014

0.11 (0.002 - 0.21)$

0.046

   Any aortic stenosis

7 (50%)

3 (21%)

4 (29%)

0.25

-0.008 (-0.022 - 0.005)$

0.23

   Estimated PAP (mmHg)

33 (26 - 36)

33 (29 - 37)

37 (33 - 40)

0.015

0.008 (-0.020 - 0.035)£

0.56

  1. Abbreviations: EDD, end-diastolic diameter; ESD, end-systolic diameter; LV, left ventricular; PAP, pulmonary artery pressure.
  2. *Echocardiographic parameters (median (IQR)) compared between gender-specific tertiles of NT-proBNP using the Jonckheere-Terpstra test (continuous variables) or the Chi-Square test with linear-by-linear association (proportions). Median values of NT-proBNP levels were 143.2 pg/mL (IQR 103.3-220.7 pg/mL) in the first tertile, 380.6 pg/mL (IQR 326.2-499.4 pg/mL) in the second tertile and 1324.0 pg/mL (IQR 762.4-2832.0 pg/mL) in the third tertile.
  3. ** Linear regression analysis with LogNT-proBNP as dependent variable and all echocardiographic measurements (except estimated PAP) as independent variables, adjusted for gender, BMI, renal function, anemia and medications for heart failure (n = 56).
  4. $ In the linear regression analysis the degree of mitral and aortic regurgitation were expressed as ordinal variables (1 to 4) and aortic stenosis was expressed as a continuous variable using the aortic valve peak gradient.
  5. £ Linear regression analysis with LogNT-proBNP as dependent variable and all echocardiographic measurements AND estimated PAP as independent variables, adjusted for gender, BMI, renal function, anemia and medications for heart failure (n = 37).